Stefania L. Nicoletti
Rimini, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.
Journal: ESMO real world data and digital oncology
Published: April 03, 2026
Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.
Journal: JAMA network open
Published: November 03, 2025
Cardiac arrest in school: the role of teachers as BLS-D providers
Journal: Giornale italiano di cardiologia (2006)
Published: June 25, 2024
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study.
Journal: BMC cancer
Published: March 03, 2024
Maintenance based Bevacizumab versus complete stop or continuous therapy after induction therapy in first line treatment of stage IV colorectal cancer: A meta-analysis of randomized clinical trials.
Journal: Critical reviews in oncology/hematology
Published: June 25, 2015
The use of indocyanine green to detect sentinel nodes in breast cancer: a prospective study.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: April 08, 2014
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib.
Journal: British journal of cancer
Published: March 21, 2013
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients.
Journal: Journal of translational medicine
Published: December 17, 2012
Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 18, 2012
Ipilimumab in advanced melanoma: reports of long-lasting responses.
Journal: Melanoma research
Published: April 21, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026